Norian is an injectable calcium phosphate bone cement used to fill bone defects and reinforce fracture repairs, primarily in the wrist, heel, shinbone, and skull. It works by hardening inside the body into a mineral similar to natural bone, giving surgeons a way to stabilize fractures without harvesting bone from the patient’s own hip or leg. The material has a strong track record in certain orthopedic and craniofacial settings, but its behavior after implantation, including slow resorption and a tendency to migrate outside the bone, makes it a more nuanced choice than it might first appear.
What Norian Is Made Of and How It Sets
Norian SRS (which stands for Skeletal Repair System) is a powder-and-liquid system. The powder contains alpha-tricalcium phosphate, monocalcium phosphate monohydrate, and calcium carbonate. When mixed with a sodium phosphate solution, these react to form a paste that can be injected or molded directly into a bone defect. The paste sets in roughly ten minutes, hardening into a form of carbonated apatite that closely resembles the mineral phase of natural bone.1Orthopedic Clinics of North America. Clinical Applications of Bone Graft Substitutes That chemical similarity is the whole point: the body recognizes the material as something bone cells can interact with rather than a foreign implant to wall off.
Once set, Norian has high compressive strength, which is why it performs well in fracture sites that need immediate structural support. Its total porosity, however, is extremely low, measured at around 0.5% in one comparative study of bone substitutes, the lowest of the materials tested.2BMC Musculoskeletal Disorders. Microstructure and biomechanical characteristics of bone substitutes for trauma and orthopaedic surgery That low porosity is a double-edged feature: it contributes to mechanical strength but also affects how quickly (or slowly) the material breaks down and is replaced by living bone.
Wrist Fractures Are the Best-Studied Use
The largest body of clinical evidence for Norian involves distal radius fractures, the common break near the wrist that accounts for a huge share of emergency-room visits, especially among older adults with weakened bones. Surgeons inject the cement into the fracture site to fill the gap left by crushed bone, providing internal buttressing that holds the fragments in place while the bone heals around it.
A randomized trial comparing Norian SRS with conventional fixation (pins and casting) in distal radius fractures found meaningful early advantages. At six to eight weeks after surgery, patients treated with Norian had better grip strength, wrist range of motion, finger movement, and less swelling. By three months most of those differences had evened out, though digital motion remained better in the Norian group. At one year, no clinical differences were detected between the groups.3PubMed. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study
A separate randomized study of 40 patients with re-displaced distal radius fractures compared Norian SRS with external fixation (a frame anchored outside the skin). Again, the Norian group recovered grip strength, wrist extension, and forearm rotation faster, with differences visible at seven weeks. By three months the functional outcomes were similar. The researchers attributed the faster early recovery to shorter immobilization time, since the cement provided enough internal support that patients did not need to stay in rigid external hardware as long.4PubMed. Norian SRS versus external fixation in redisplaced distal radial fractures. A randomized study in 40 patients
In osteoporotic patients specifically, a study of intra-articular (joint-involving) distal radius fractures found that supplementing pin-and-screw fixation with Norian SRS dramatically reduced the loss of fracture reduction over time. The Norian group lost only about 1 mm of radial length, compared with 3 mm in the control group, and the loss of angular alignment was roughly half or less. The authors concluded that the cement was effective at maintaining reduction in osteoporotic bone, where conventional hardware alone tends to loosen.5PubMed. Injectable calcium phosphate bone cement Norian SRS for the treatment of intra-articular compression fractures of the distal radius in osteoporotic women
The consistent finding across these trials is that Norian accelerates early recovery rather than changing the final outcome. At one year most patients end up in the same place regardless of treatment method. For someone who needs to get back to daily function quickly, that early advantage matters, but it is worth understanding that the long-term destination is similar.
Lower Limb Applications
Beyond the wrist, Norian has been used in calcaneal (heel bone) fractures and tibial plateau fractures, both of which involve joint surfaces that collapse under impact and leave voids in the underlying spongy bone.
In a series of 12 displaced calcaneal fractures treated with percutaneous (through-the-skin) reduction and Norian SRS injection, all cases achieved adequate alignment on post-operative X-rays. Patients began full weight bearing at one month, and none showed loss of reduction on follow-up imaging. No wound complications or cement-related soft tissue reactions were reported.6PubMed. Percutaneous reduction and injection of Norian bone cement for the treatment of displaced intra-articular calcaneal fractures The percutaneous technique is a selling point here: traditional open surgery for heel fractures involves large incisions with notoriously high wound-complication rates, so any approach that can stabilize the fracture through a small puncture is attractive.
For tibial plateau fractures, a prospective study with 30-month follow-up found that Norian SRS effectively filled the metaphyseal bone defects and produced clinical and radiological results comparable to autologous bone graft (bone taken from the patient’s own body). The cement’s compressive strength was high enough to allow early full weight bearing without secondary collapse of the joint surface.7PubMed. Use of the injectable bone cement Norian SRS for tibial plateau fractures. Results of a prospective 30-month follow-up study Autologous graft has long been the gold standard for filling bony voids, but it requires a second surgical site and causes donor-site pain, so matching its performance with an injectable cement is a practical win.
Craniofacial Reconstruction
Norian has also found a role in repairing skull defects, particularly in children who have undergone previous surgeries for craniofacial anomalies and are left with frontal or cranial surface irregularities. A pediatric series at Hospital La Paz described using Norian SRS to smooth out these contour deformities, where the main indication was correcting the cosmetic and structural aftermath of earlier reconstructive operations.8Journal of Oral and Maxillofacial Surgery. Clinical applications of Norian SRS (calcium phosphate cement) in craniofacial reconstruction in children: Our experience at Hospital La Paz since 2001
In the skull, Norian behaves somewhat differently than in long bones. A comparative animal study of cranioplasty materials found that Norian maintained high stiffness and produced the strongest healed defect among the materials tested. However, the cement was not replaced by bone the way some other materials are. Instead, it remained solid and served as a permanent scaffold, with bone growing around and against it rather than through it.9Journal of Craniofacial Surgery. The Use of Novabone and Norian in Cranioplasty: A Comparative Study That distinction matters for surgeons choosing a material: Norian in the skull acts more like a structural filler than a temporary placeholder that dissolves as new bone takes over.
Cement Migration and Other Complications
The most common complication with Norian is cement escaping beyond the bone. In the large randomized trial of distal radius fractures, cement was found in extraosseous (outside-the-bone) locations in about 70% of patients treated with Norian SRS. Loss of fracture reduction was highest in that subgroup, at 37%. Four patients had cement leak into the joint space, though none experienced lasting problems from it at two years. In the majority of cases where cement migrated outside the bone, the material had disappeared on imaging by twelve months, suggesting the body gradually resorbed the displaced cement.3PubMed. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study
That 70% extraosseous rate sounds alarming, and it deserves context. Most of those cases involved small amounts of cement visible on X-rays but causing no symptoms. The clinical reality is that injectable cement is difficult to contain perfectly within a fractured bone, especially one with cortical breaks that provide channels for material to escape. The reassuring finding is that the overall complication rate, including loss of reduction, was not significantly different between the Norian group and the conventional-fixation group in that trial. Cement leakage is common but typically benign.
Still, the association between extraosseous cement and higher rates of reduction loss raises a practical question for surgeons: does the cement escaping the fracture site leave less material inside to do its stabilizing job? The data suggest this is at least partly the case. Careful injection technique, minimizing the volume of cement that escapes cortical defects, likely matters for outcomes.
Resorption and What Happens Over Time
One of the persistent questions about any bone substitute is whether it eventually disappears and gets replaced by the patient’s own bone, or whether it stays put indefinitely. With Norian, the answer depends on where in the body you are looking and what timeframe you are considering.
The microstructural arrangement of the cement’s apatite crystals plays a major role in how quickly the body can break it down. Research comparing Norian to another injectable apatitic cement (Graftys HBS) found that differences in how each cement creates internal porosity led to very different resorption rates in an animal model of bone defects, despite both being chemically similar calcium phosphate apatites. Norian’s particular crystal arrangement and low permeability were associated with slower degradation.10Journal of Biomedical Materials Research Part B. In vivo resorption of injectable apatitic calcium phosphate cements: Critical role of the intergranular microstructure
In the skull, a sheep model evaluating Norian’s craniofacial repair formulations over 12 months found that while the cement fully osseointegrated (bonded with the surrounding bone), there was little osteoconduction, meaning new bone did not grow extensively through the material itself.11Plastic and Reconstructive Surgery. Biomechanical and Histologic Evaluation of the Norian Craniofacial Repair System and Norian Craniofacial Repair System Fast Set Putty in the Long-Term Reconstruction of Full-Thickness Skull Defects in a Sheep Model The practical implication is that Norian in cranial applications functions more as a permanent implant than a temporary scaffold. For fracture sites in the limbs, where the surrounding bone is metabolically active and under mechanical loading, the resorption picture is somewhat more favorable, but still slow compared to some competing materials with higher porosity.
This slow resorption is not necessarily a flaw. In weight-bearing fractures where you need the filler to stay strong for months while the bone consolidates, a material that dissolves too quickly would defeat the purpose. The tibial plateau data, where patients bore full weight without collapse over 30 months, illustrate this advantage.7PubMed. Use of the injectable bone cement Norian SRS for tibial plateau fractures. Results of a prospective 30-month follow-up study The trade-off is that Norian will show up on imaging for a long time, potentially complicating the interpretation of follow-up scans, and areas filled with cement are not truly remodeled living bone.
Why Norian Has Not Caught On in the Spine
Vertebroplasty, the procedure where cement is injected into a collapsed vertebral body to stabilize it and relieve pain, might seem like a natural fit for a biocompatible calcium phosphate cement. In laboratory and animal studies, calcium phosphate cements including Norian have shown both mechanical effectiveness and good biocompatibility in vertebral models. However, clinical adoption in the spine has been limited by two practical problems: the cement is difficult to handle during injection into vertebral bodies, and it does not show up well enough on fluoroscopy (live X-ray) during the procedure.12European Spine Journal. Bone substitutes in vertebroplasty
Radiopacity, the ability to be seen clearly on X-rays in real time, is critical during vertebroplasty because the surgeon needs to watch the cement flowing inside the vertebra to avoid dangerous leakage into the spinal canal or surrounding veins. PMMA (polymethylmethacrylate), the acrylic bone cement that dominates vertebroplasty, contains barium sulfate or other contrast agents that make it brilliantly visible under fluoroscopy. Norian’s limited radiopacity makes the procedure riskier, because the surgeon cannot see as clearly where the cement is going. This limitation, combined with handling difficulties like the cement’s relatively fast setting time and paste consistency, has kept calcium phosphate cements on the sidelines in spinal applications despite their theoretical biocompatibility advantages.
How Norian Compares to Other Filling Options
The three broad categories of bone void fillers that Norian competes with are autologous bone graft, other synthetic ceramics, and PMMA bone cement. Each has distinct strengths.
Autologous bone graft remains the biological gold standard because it contains living bone cells, growth factors, and a natural mineral scaffold. Its main drawback is donor-site morbidity: harvesting bone from the iliac crest (hip) causes pain and can lead to its own complications. Norian eliminates that second surgical site entirely while, in at least one study, producing comparable results in tibial plateau fractures over 30 months.7PubMed. Use of the injectable bone cement Norian SRS for tibial plateau fractures. Results of a prospective 30-month follow-up study
PMMA bone cement is stronger in tension and far more visible on imaging, which is why it dominates in vertebroplasty and joint replacement. But PMMA is biologically inert: the body walls it off with fibrous tissue rather than integrating it into bone. It also generates heat as it hardens, which can damage surrounding tissue. Norian sets at body temperature and is at least partially bioactive, meaning bone can grow directly against it. For fracture augmentation in areas like the wrist or heel, that bioactivity gives Norian an edge.
Other synthetic calcium phosphate and calcium sulfate cements vary widely in porosity, resorption rate, and mechanical strength. Some competing products have much higher porosity, which promotes faster bone ingrowth but at the cost of lower initial strength. Norian sits at the extreme low-porosity end of this spectrum.2BMC Musculoskeletal Disorders. Microstructure and biomechanical characteristics of bone substitutes for trauma and orthopaedic surgery The choice between these materials often comes down to whether the clinical situation demands immediate structural support (favoring Norian) or rapid biological incorporation (favoring a more porous alternative).
Reinforcing Hardware With Calcium Phosphate Cement
A related use for calcium phosphate cements is screw augmentation, where the cement is injected around orthopedic screws to improve their grip in weak or osteoporotic bone. A sheep model testing a fiber-reinforced calcium phosphate cement for this purpose found that screw-holding strength was significantly higher with the reinforced cement at the time of implantation compared to non-reinforced cement. After 12 weeks in the body, the pullout strength of the fiber-reinforced cement increased by 45% in smaller defects compared to its initial value, suggesting that biological integration over time further strengthened the fixation.13PubMed Central. Evaluation of a fiber reinforced drillable bone cement for screw augmentation in a sheep model–mechanical testing While this specific study tested a fiber-reinforced formulation rather than standard Norian, it illustrates the broader principle behind using calcium phosphate cements to shore up hardware in compromised bone, a scenario that comes up frequently in osteoporotic fracture repair and revision surgery.
The idea of a cement that gets stronger over time as bone grows into it is appealing, and it distinguishes the calcium phosphate family from PMMA, which is as strong as it will ever be the moment it sets. Whether these animal-model gains in pullout strength translate reliably into fewer hardware failures in human patients is still an area where clinical data is catching up with the laboratory promise.